Global re-emergence of dengue fever: The need for a rapid response and surveillance
The Microbe,
Год журнала:
2024,
Номер
4, С. 100107 - 100107
Опубликована: Июнь 26, 2024
Dengue
fever
virus
(DENV)
is
a
mosquito-borne
mostly
spread
by
Aedes
aegypti.
According
to
the
World
Health
Organization,
DENV
found
primarily
in
urban
and
semiurban
areas
tropical
subtropical
climates
globally,
putting
approximately
half
of
world's
population
at
risk,
where
about
100–400
million
cases
disease
occur
annually.
In
2023
alone,
there
were
over
five
dengue
reported
more
than
80
countries
territories
worldwide.
This
due
an
ongoing
outbreak
potentiated
unanticipated
spike
cases.
It
crucial
understand
transmission
patterns
manage
public
health
effectively.
Here,
we
provide
overview
recent
global
propose
integrated/coordinated
system
(One
Health)
as
recommendation
for
effective
prevention
control
measure.
Язык: Английский
The mosquito knows no borders: Regional challenges for global confrontation in the dengue battle
PLoS neglected tropical diseases,
Год журнала:
2024,
Номер
18(1), С. e0011830 - e0011830
Опубликована: Янв. 4, 2024
Язык: Английский
Assessment of Abnormal Liver Function Tests in Dengue Fever: Implications for Disease Severity and Outcome
Indus journal of bioscience research.,
Год журнала:
2025,
Номер
3(4), С. 144 - 149
Опубликована: Апрель 13, 2025
Background
and
Objective:
Dengue
fever,
a
significant
tropical
disease,
often
presents
with
liver
dysfunction.
This
study
evaluated
the
association
between
elevated
function
tests
(AST,
ALT,
bilirubin)
clinical
outcomes
mortality,
to
identify
prognostic
indicators.
Material
&
Methods:
cross-sectional
was
conducted
in
department
of
Medicine,
Nishtar
Hospital,
Multan,
over
15-month
period
from
July
2024
September
2024.
Patients
confirmed
dengue
fever
were
enrolled
using
non-probability
consecutive
sampling
technique.
Statistical
analysis
performed
SPSS
version
26.0.
Results:
A
total
146
patients
included,
mean
age
48
±
17
years;
most
common
group
31
45
years
(32%).
Males
constituted
78
(53%)
sample.
(DF)
identified
85
(58%),
hemorrhagic
(DHF)
37
(25%)
shock
syndrome
(DSS)
24
(16%).
AST
ALT
levels
significantly
DSS
(670.4
701.5
U/L
700.8
750.3
U/L)
compared
DHF
(550.7
660.3
560.4
720.8
DF
(482.8
645.6
496.1
683.1
(p
<
0.001).
Mortality
38%
11%
(p<0.001).
AST,
bilirubin
higher
non-survivors
Severe
dysfunction
(AST
+
>
300
associated
increased
mortality.
Conclusion:
highlights
strong
LFTs
severe
outcomes,
underscoring
their
value
assessing
severity
guiding
interventions.
Язык: Английский
Fractional-order modeling of dengue dynamics: exploring reinfection mechanisms with the Atangana–Baleanu derivative
Modeling Earth Systems and Environment,
Год журнала:
2025,
Номер
11(4)
Опубликована: Май 31, 2025
Язык: Английский
Dengue virus serotype did not contribute to clinical severity or mortality in Taiwan’s largest dengue outbreak in 2015
European journal of medical research,
Год журнала:
2023,
Номер
28(1)
Опубликована: Ноя. 6, 2023
Abstract
Background
Dengue
virus
serotype
2
(DENV-2)
was
the
major
in
2015
dengue
outbreak
Taiwan,
while
DENV-1
and
DENV-3
were
dominant
between
2005
2014.
We
aimed
to
investigate
whether
DENV-2
contributed
disease
severity
mortality
Kaohsiung
city,
Taiwan.
Methods
collected
serum
samples
from
patients
detect
presence
of
DENV
determine
serotypes
by
using
quantitative
reverse
transcription-polymerase
chain
reaction.
Our
cohorts
comprised
105
DENV-1-infected
cases
1,550
DENV-2-infected
cases.
Demographic
data,
serotype,
comorbidities
covariates
for
univariate
multivariate
analyses
explore
association
with
mortality.
Results
The
results
suggested
that
persisted
circulated,
during
occurred
September
December
2015.
However,
did
not
directly
contribute
either
or
Aged
diabetes
mellitus
(DM)
moderate
severe
chronic
kidney
(CKD)
had
a
higher
risk
developing
dengue.
related
Charlson
comorbidity
index
score
Among
older
patients,
preexisting
anti-dengue
IgG,
DM,
CKD
associated
Moreover,
female
sex
significantly
death.
Conclusions
findings
highlight
importance
timely
serological
testing
elderly
identify
potential
secondary
infections
focus
on
meticulous
management
DM
reduce
dengue-related
Язык: Английский
Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection
Journal of Virology,
Год журнала:
2024,
Номер
98(4)
Опубликована: Март 28, 2024
ABSTRACT
Dengue
fever,
an
infectious
disease
prevalent
in
subtropical
and
tropical
regions,
currently
lacks
effective
small-molecule
drugs
as
treatment.
In
this
study,
we
used
a
fluorescence
peptide
cleavage
assay
to
screen
seven
compounds
assess
their
inhibition
of
the
dengue
virus
(DENV)
NS2B-NS3
protease.
DV-B-120
demonstrated
superior
protease
activity
lower
toxicity
compared
ARDP0006.
The
selectivity
index
was
higher
than
that
vivo
assessments
antiviral
efficacy
against
DENV
replication
delayed
mortality
suckling
mice
treated
with
compound,
60–80%
protection
life-threatening
effects,
outcomes
DENV-infected
saline.
clinical
scores
indicated
reduction
acute–progressive
illness
symptoms,
underscoring
potential
therapeutic
impact
DV-B-120.
Investigations
DV-B-120's
ability
restore
type
I
IFN
response
brain
tissue
ICR
its
capacity
stimulate
IFN-stimulated
gene
expression.
not
only
significantly
DENV-2-induced
symptoms
but
also
reduced
viral
numbers
brain,
ultimately
restoring
innate
response.
These
findings
strongly
suggest
holds
promise
agent
infection
highlight
contribution
addressing
current
lack
treatments
for
disease.
IMPORTANCE
prevalence
regions
is
escalating
due
factors
like
climate
change
mosquito
vector
expansion.
With
over
300
million
annual
infections
potentially
fatal
outcomes,
urgent
need
evident.
While
approved
Dengvaxia
vaccine
has
variable
efficacy,
there
are
no
DENV.
This
study
explores
targeting
protease,
crucial
protein
replication.
exhibit
inhibitory
effects
on
DENV-2
NS2B-NS3,
holding
disrupting
preventing
severe
manifestations.
However,
further
research,
including
animal
testing,
imperative
toxicity.
Developing
safe
potent
critical
rising
global
health
threat
posed
by
virus.
Язык: Английский
Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(21), С. 11624 - 11624
Опубликована: Окт. 29, 2024
Extensive
research
has
been
conducted
on
the
SARS-CoV-2
virus
in
association
with
various
infectious
diseases
to
understand
pathophysiology
of
infection
and
potential
co-infections.
In
tropical
countries,
exposure
local
viruses
may
alter
course
coinfection.
Notably,
only
a
portion
antibodies
produced
against
proteins
demonstrate
neutralizing
properties,
immune
response
following
natural
tends
be
temporary.
contrast,
long-lasting
IgG
are
common
after
dengue
infections.
cases
where
preexisting
from
an
initial
bind
different
serotype
during
subsequent
infection,
there
is
for
antibody-dependent
enhancement
(ADE)
formation
complexes
associated
disease
severity.
Both
infections
can
result
immunodeficiency.
Viral
both
interfere
host's
IFN-I
signaling.
Additionally,
cytokine
storm
occur
viral
impairing
proper
response,
autoantibodies
wide
array
appear
convalescence.
Most
reported
typically
short-lived.
Vaccines
affecting
enhancing
clearance.
A
comprehensive
analysis
pathogenicity
revisited
prevent
severity,
mortality.
Язык: Английский
Effect of C-type lectin 16 on dengue virus infection in Aedes aegypti salivary glands
PNAS Nexus,
Год журнала:
2024,
Номер
3(5)
Опубликована: Апрель 30, 2024
C-type
lectins
(CTLs)
are
a
family
of
carbohydrate-binding
proteins
and
an
important
component
mosquito
saliva.
Although
CTLs
play
key
roles
in
immune
activation
viral
pathogenesis,
little
is
known
about
their
role
regulating
dengue
virus
(DENV)
infection
transmission.
In
this
study,
we
established
homozygous
Язык: Английский